If the average 2023 price target of $30.81 recently set by prominent experts for Aerpio Pharmaceuticals is met, there would be a potential upside of approximately 10.35% from the last closing price in September, 2021. The high estimate is $34.51, and the low is $27.42.

$30.81

10.35% Upside

Aerpio Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals's Price has seen growth In the last year, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $24.48 – an increase of 100.00%. For the next ten years, the forecast is forFair Value to grow by 100.00%.

2021 Fair Value Forecast

$24.48

2022 Fair Value Forecast

$27.60

2023 Fair Value Forecast

$30.73

2024 Fair Value Forecast

$34.17

2025 Fair Value Forecast

$37.99

2026 Fair Value Forecast

$42.24

2027 Fair Value Forecast

$46.97

2028 Fair Value Forecast

$52.22

2029 Fair Value Forecast

$58.07

2030 Fair Value Forecast

$64.57

Aerpio Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's Free Cash Flow has gone down from $-24.09M to $-5.40M – a 77.58% drop. In the next year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $-24.09M – an increase of 346.11%. The Aerpio Pharmaceuticals forecast is for Free Cash Flow to reach $-44.25M or grow by 719.50%.

2021 FCF Forecast

$-24089940.00

2022 FCF Forecast

$-39423186.81

2023 FCF Forecast

$-69600322.21

2024 FCF Forecast

$-32519590.55

2025 FCF Forecast

$-35964499.17

2026 FCF Forecast

$-43288070.02

2027 FCF Forecast

$-55918085.91

2028 FCF Forecast

$-46768023.12

2029 FCF Forecast

$-43657949.59

2030 FCF Forecast

$-44253152.96

Aerpio Pharmaceuticals Net Income Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's Net Income has seen a drop from $-23.27M to $-4.32M – a 81.44% decrease. In the next year, analysts predict that Net Income will reach $-23.27M – an increase of 438.66%. For the next ten years, the forecast is for Net Income to grow by 1198.10%.

2021 NI Forecast

$-23270112.00

2022 NI Forecast

$-44661550.29

2023 NI Forecast

$-90710586.08

2024 NI Forecast

$-36253997.57

2025 NI Forecast

$-42483642.82

2026 NI Forecast

$-54490936.40

2027 NI Forecast

$-75108490.37

2028 NI Forecast

$-59047791.51

2029 NI Forecast

$-54660540.60

2030 NI Forecast

$-56078070.62

Aerpio Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's EBITDA has fallen from $-22.50M to $-6.30M – a 72.00% decrease. For next year, the 0 analysts predict EBITDA of $-22.50M, which would mean an increase of 257.14%. Over the next ten years, the pros' prediction is EBITDAof $-32.07M, which would mean a ten-year growth forecast of 409.12%.

2021 EBITDA Forecast

$-22499820.00

2022 EBITDA Forecast

$-30985252.12

2023 EBITDA Forecast

$-47278330.52

2024 EBITDA Forecast

$-26184315.39

2025 EBITDA Forecast

$-27817343.86

2026 EBITDA Forecast

$-31547649.67

2027 EBITDA Forecast

$-38158985.45

2028 EBITDA Forecast

$-33704559.88

2029 EBITDA Forecast

$-31914847.75

2030 EBITDA Forecast

$-32074421.99

Aerpio Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's EBIT has decreased from $-22.58M to $-6.36M – a 71.83% drop. In the next year, analysts expect EBIT to reach $-22.58M – an increase of 255.03%. For the next ten years, the forecast is for EBIT to grow by 403.20%.

2021 EBIT Forecast

$-22579908.00

2022 EBIT Forecast

$-30962322.51

2023 EBIT Forecast

$-47076147.23

2024 EBIT Forecast

$-26185322.29

2025 EBIT Forecast

$-27798338.15

2026 EBIT Forecast

$-31481617.95

2027 EBIT Forecast

$-38017201.84

2028 EBIT Forecast

$-33621146.06

2029 EBIT Forecast

$-31849311.67

2030 EBIT Forecast

$-32003250.01

Aerpio Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals's EPS has seen growth In the last year, going from $-0.53 to $-1.50 – a gain of 183.02% According to 0 prominent analysts, Aerpio Pharmaceuticals's EPS will fall by 64.67% in the next year, reaching $-0.53. By 2030, professionals believe that Aerpio Pharmaceuticals's EPS will decrease by 10.64%, reaching $-1.34 – a concerning trend for the company.

2021 EPS Forecast

$-0.53

2022 EPS Forecast

$-1.06

2023 EPS Forecast

$-1.30

2024 EPS Forecast

$-1.80

2025 EPS Forecast

$-1.22

2026 EPS Forecast

$-1.23